I used three probiotics starting week 36 of my pregnancy to recover from a short round of antibiotics and prepare for breastfeeding. These three probiotics support different parts of the system: LGG helps shape immune signals passed through breastmilk. Saccharomyces boulardii protects against yeast and antibiotic-related gut disruption. Bacillus coagulans stabilizes the maternal gut and reduces inflammation. Together, they support the gut–immune–breastmilk pathway during recovery.
Lactobacillus rhamnosus GG (LGG)
LGG is one of the most studied probiotic strains in pregnancy and lactation. Its main value during breastfeeding is immune programming via breastmilk, not vaginal effects.
1. LGG increases immune antibodies (IgA) in breastmilk
LGG has been shown to:
-
stimulate gut-associated immune tissue (GALT)
-
increase production of secretory IgA
-
influence immune signals that reach the mammary gland
Higher IgA in breastmilk helps:
-
coat the infant gut
-
reduce pathogen attachment
-
support immune tolerance
Research:
-
Maternal LGG supplementation increases IgA and immune markers
https://pubmed.ncbi.nlm.nih.gov/23842197/ -
Probiotic-induced immune modulation during lactation
https://pubmed.ncbi.nlm.nih.gov/23244822/
2. LGG reduces inflammatory signaling passed to the infant
LGG helps:
-
downregulate pro-inflammatory cytokines
-
support balanced immune signaling
-
reduce exaggerated immune responses
This matters because early immune overactivation is linked to:
-
eczema
-
food sensitivities
-
allergic disease
Research:
-
LGG reduces inflammatory responses and supports immune balance
https://pubmed.ncbi.nlm.nih.gov/26365568/ -
Maternal probiotics and infant immune outcomes
https://pubmed.ncbi.nlm.nih.gov/20181842/
3. LGG is linked to lower infant eczema and allergy risk
Several studies show that when LGG is used during pregnancy and lactation:
-
infants have lower rates of eczema
-
immune tolerance develops more smoothly
This effect is strain-specific — it does not apply to all Lactobacillus species.
Research:
-
Reduced infant eczema with maternal LGG use
https://pubmed.ncbi.nlm.nih.gov/12182371/ -
Long-term immune effects of LGG exposure
https://pubmed.ncbi.nlm.nih.gov/15723916/
4. LGG supports maternal gut barrier integrity
LGG:
-
strengthens tight junctions in the gut lining
-
reduces intestinal permeability
-
lowers systemic inflammation
A healthier maternal gut supports:
-
better nutrient absorption
-
steadier milk production
-
calmer immune signaling
Research:
-
LGG improves gut barrier function
https://pubmed.ncbi.nlm.nih.gov/15220665/
5. LGG is well-studied and considered safe during breastfeeding
LGG has:
-
extensive human safety data
-
no evidence of harm in breastfeeding women
-
been used in many maternal–infant studies
Research:
-
Safety of LGG in pregnancy and lactation
https://pubmed.ncbi.nlm.nih.gov/17369095/
What LGG does not do
-
It does not rapidly restore the vaginal microbiome
-
It does not act immediately (effects take days–weeks)
-
It does not directly seed the infant gut
How Bacillus coagulans is useful while breastfeeding (with research)
Bacillus coagulans doesn’t help breastfeeding by “going into the milk” or directly colonizing the baby. It helps by stabilizing the mother’s gut and immune system, which then shapes breastmilk composition and immune signaling to the infant.
1. It survives digestion and antibiotics
B. coagulans is spore-forming, meaning it can survive:
-
stomach acid
-
bile
-
many antibiotics
This makes it particularly useful postpartum, when gut flora is often disrupted by:
-
intrapartum antibiotics
-
postpartum antibiotics
-
physiological stress
Research:
-
Survival of B. coagulans spores through gastric conditions
https://pubmed.ncbi.nlm.nih.gov/23858019/ -
Stability and viability compared to non-spore probiotics
https://pubmed.ncbi.nlm.nih.gov/24784399/
Why this matters for breastfeeding: a probiotic that doesn’t survive digestion can’t reliably influence maternal gut–immune signaling.
2. It supports the gut–immune–breastmilk axis
Breastmilk immune components (especially secretory IgA) are strongly influenced by what’s happening in the mother’s gut.
B. coagulans helps by:
-
modulating gut-associated lymphoid tissue (GALT)
-
reducing gut inflammation
-
supporting balanced immune signaling
This can translate to more stable immune factors in breastmilk, even though the bacteria itself usually doesn’t enter milk.
Research:
-
Probiotics influence maternal immune responses and IgA signaling
https://pubmed.ncbi.nlm.nih.gov/26365568/ -
Gut immune modulation affecting mammary gland immunity
https://pubmed.ncbi.nlm.nih.gov/23244822/
3. It promotes short-chain fatty acid (SCFA) production
B. coagulans supports production of SCFAs (such as butyrate and acetate), which:
-
strengthen the gut barrier
-
reduce inflammation
-
promote immune tolerance
SCFAs act as signaling molecules that influence:
-
maternal immune tone
-
breastmilk immune composition
-
infant immune development
Research:
-
B. coagulans and SCFA production
https://pubmed.ncbi.nlm.nih.gov/23642950/ -
Role of SCFAs in immune regulation and gut barrier integrity
https://pubmed.ncbi.nlm.nih.gov/28416421/
4. It helps reduce antibiotic-associated gut disruption
Postpartum antibiotics can increase the risk of:
-
diarrhea
-
yeast overgrowth
-
prolonged dysbiosis
B. coagulans has been shown to:
-
reduce antibiotic-associated diarrhea
-
support faster gut recovery
This indirectly supports breastfeeding by improving:
-
maternal nutrient absorption
-
hydration status
-
overall postpartum recovery
Research:
-
Reduction of antibiotic-associated diarrhea with B. coagulans
https://pubmed.ncbi.nlm.nih.gov/25569939/ -
Clinical safety and tolerability
https://pubmed.ncbi.nlm.nih.gov/24667895/
5. It is generally well tolerated during breastfeeding
Compared to some probiotics, B. coagulans:
-
causes less gas and bloating
-
is less likely to worsen reflux
-
has a strong safety profile in adults
This matters postpartum, when digestion is often fragile and sleep deprivation amplifies GI discomfort.
Research:
-
Safety profile of Bacillus coagulans in human use
https://pubmed.ncbi.nlm.nih.gov/28165804/
What Bacillus coagulans does not do
It’s important to be clear:
-
It does not directly seed the infant gut like Bifidobacterium
-
It does not replace vaginal probiotics
-
It does not act instantly on the vaginal microbiome
It works indirectly and systemically, over days to weeks.
Bottom line
During breastfeeding, Bacillus coagulans is useful because it:
-
survives digestion and antibiotics
-
stabilizes the maternal gut
-
reduces inflammation
-
supports immune signaling into breastmilk
-
is gentle and well tolerated postpartum
Think of it as infrastructure support for breastfeeding — not the star player, but essential for stability.
Saccharomyces boulardii
S. boulardii is a beneficial yeast, not a bacterium. Its biggest role during breastfeeding is yeast control and antibiotic recovery.
1. It is not killed by antibiotics
Because it’s a yeast:
-
antibiotics do not affect it
-
it can be taken during or after antibiotics
-
it remains active when bacterial probiotics fail
This is especially useful postpartum, when antibiotics are common.
Research:
-
Antibiotic resistance of S. boulardii
https://pubmed.ncbi.nlm.nih.gov/22301796/
2. It suppresses Candida overgrowth
S. boulardii:
-
competes with Candida for space and nutrients
-
produces compounds that inhibit yeast adhesion
-
reduces Candida virulence
This matters during breastfeeding because Candida can cause:
-
nipple thrush
-
infant oral thrush
-
recurrent yeast issues after antibiotics
Research:
-
S. boulardii inhibition of Candida
https://pubmed.ncbi.nlm.nih.gov/15780398/ -
Prevention of recurrent yeast overgrowth
https://pubmed.ncbi.nlm.nih.gov/19774555/
3. It helps prevent antibiotic-associated diarrhea
S. boulardii has strong evidence for:
-
reducing antibiotic-associated diarrhea
-
shortening duration of GI upset
-
stabilizing gut function
Better maternal gut health supports:
-
hydration
-
nutrient absorption
-
milk production
Research:
-
Meta-analysis on S. boulardii and antibiotic-associated diarrhea
https://pubmed.ncbi.nlm.nih.gov/20083093/
4. It supports gut barrier and immune signaling
S. boulardii:
-
reduces gut inflammation
-
strengthens mucosal defenses
-
modulates immune signaling without overstimulation
These signals indirectly influence breastmilk immune composition.
Research:
-
Immune-modulating effects of S. boulardii
https://pubmed.ncbi.nlm.nih.gov/16469676/
5. It is generally safe during breastfeeding (with one caveat)
For healthy breastfeeding women:
-
S. boulardii is considered safe
-
adverse effects are rare
⚠️ Caution:
It should be avoided in severely immunocompromised individuals or those with central venous catheters (rare in postpartum settings, but important to state).
Research:
-
Safety profile of S. boulardii
https://pubmed.ncbi.nlm.nih.gov/24667895/
What Saccharomyces boulardii does NOT do
-
It does not colonize long-term
-
It does not directly seed the infant gut
-
It does not replace Lactobacillus probiotics
Bottom line (breastfeeding context)
LGG
-
immune programming
-
higher IgA in milk
-
lower infant eczema risk
-
gut barrier support
S. boulardii
-
yeast control
-
antibiotic resilience
-
diarrhea prevention
-
gut stabilization
They work best together, and alongside:
-
diet
-
vaginal probiotics (for birth-related protection)
-
spore-formers like B. coagulans
| Feature / Role | Lactobacillus rhamnosus GG (LGG) | Saccharomyces boulardii | Bacillus coagulans |
|---|---|---|---|
| Type | Bacterial probiotic (Lactobacillus) | Beneficial yeast | Spore-forming bacterium |
| Survives antibiotics? | ❌ No (antibiotics reduce it) | ✅ Yes (not affected) | ✅ Yes (spore-forming) |
| Survives stomach acid? | ⚠️ Partially (strain-dependent) | ✅ Yes | ✅ Yes |
| Primary role during breastfeeding | Immune programming via breastmilk | Yeast control + gut stabilization | Maternal gut + immune stabilization |
| Main mechanism | Increases IgA and immune balance | Competes with Candida, stabilizes gut | Reduces inflammation, supports SCFAs |
| Effect on breastmilk | ↑ IgA, improved immune signaling | Indirect (via maternal gut health) | Indirect (via immune tone + SCFAs) |
| Effect on infant outcomes | ↓ eczema / allergy risk | ↓ thrush risk (indirect) | Supports immune tolerance (indirect) |
| Candida / yeast control | ❌ Minimal | ✅ Strong | ⚠️ Indirect |
| Antibiotic-associated diarrhea | ⚠️ Limited | ✅ Strong evidence | ✅ Moderate evidence |
| Gut barrier support (mother) | ✅ Strong | ✅ Moderate | ✅ Strong |
| Gas / bloating risk | ⚠️ Moderate (some women) | ⚠️ Low–moderate | ✅ Low |
| Speed of effect | Days–weeks | Days | Days–weeks |
| Direct vaginal effect | ❌ No | ❌ No | ❌ No |
| Best timing | Pregnancy + breastfeeding | During & after antibiotics | During & after antibiotics |
| Safety during breastfeeding | ✅ Well studied | ✅ Yes* | ✅ Yes |
| Important caveat | Needs consistency | Avoid if severely immunocompromised | Not a vaginal probiotic |
Check out our vaginal test give-away raffle if you are curious about your vaginal microbiome!